Treatment for Thyroid Cancer and other Endocrine Cancers in New Jersey
At Hackensack Meridian Health, the treatment of thyroid and other endocrine cancers is managed by a multidisciplinary team of endocrine surgeons, endocrinologists, and other specialists. The team utilizes advanced diagnostic techniques to precisely characterize each tumor, which informs the development of a personalized treatment plan.
Diagnosing and Staging Thyroid and Endocrine Cancer
Accurate diagnosis and staging are essential for developing the right treatment plan. Common diagnostic tests for thyroid and endocrine cancers include:
Measures calcium and other substances released by organs and tissues.
Evaluates hormone levels in the body.
Creates detailed cross-sectional images of the body to identify tumors.
Examines vocal cord function to detect abnormalities.
Uses magnetic fields and radio waves to produce images of tumors and assess their spread.
Identifies the size and nature (solid or cystic) of thyroid nodules.
Thyroid and Endocrine Cancer Treatment Options
Our multidisciplinary team collaborates to develop a personalized treatment plan based on your specific needs. Treatment options for thyroid cancer and other endocrine cancers include:
Surgeons use small incisions and video-assisted scopes to remove part or all of a gland or tumor, leading to quicker healing and reduced scarring.
For larger thyroid cancers, a radioactive pill is administered post-surgery to destroy remaining cancer cells without harming surrounding tissues.
For smaller thyroid cancers, surgery may be the sole treatment.
For certain thyroid and adrenal cancers, chemotherapy or targeted therapies may be used. Our specialists select therapies based on the genetic mutations and molecular structure of the tumor.
Patient-Centered Care
At Hackensack Meridian Health, we offer the opportunity to participate in clinical trials for new, innovative treatments. Our research focuses on reducing complications and lowering the risk of disease recurrence. We are pioneers in combining checkpoint inhibitors with stem cell transplants, aiming to enhance the immune system’s ability to eliminate cancer cells after treatment.
